Fulvestrant is a selective estrogen receptor degrader (SERD) indicated for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women. By binding to estrogen receptors… Read more
![Chemical structure of (7R,7'R,8R,8'R,9S,9'S,13S,13'S,14S,14'S,17S,17'S)-7,7'-(Sulfinylbis(nonane-9,1-diyl))bis(13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F7R7R8R8R9S9S13S13S14S14S17S17S-77-Sulfinylbisnonane-91-diylbis13-methyl-78911121314151617-decahydro-6H-cyclopentaaphenanthrene-317-diol.png&w=3840&q=75)
![Chemical structure of (7R,8R,9S,10R,13S,14S,17S)-7-(9-Bromononyl)-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F875573-63-0-7R8R9S10R13S14S17S-7-9-Bromononyl-13-methyl-3-oxo-2367891011121314151617-tetradecahydro-1H-cyclopentaaphenanthren-17-yl-acetate.png&w=3840&q=75)
![Chemical structure of (7R,8R,9S,13S,14S,17R)-7-(9-Bromononyl)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F7R8R9S13S14S17R-7-9-Bromononyl-3-hydroxy-13-methyl-78911121314151617-decahydro-6H-cyclopentaaphenanthren-17-yl-acetate.png&w=3840&q=75)
![Chemical structure of (7R,8R,9S,13S,14S,17S)-7-(9-Chlorononyl)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2490287-82-4-7R8R9S13S14S17S-7-9-Chlorononyl-3-hydroxy-13-methyl-78911121314151617-decahydro-6H-cyclopentaaphenanthren-17-yl-acetate.png&w=3840&q=75)
![Chemical structure of (7S,8R,9S,13S,14S,17S)-13-Methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)thio)nonyl)-3,17-bis((tetrahydro-2H-pyran-2-yl)oxy)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-6-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2170233-15-3-7S8R9S13S14S17S-13-Methyl-7-9-44555-pentafluoropentylthiononyl-317-bistetrahydro-2H-pyran-2-yloxy-78911121314151617-decahydro-6H-cyclopen.png&w=3840&q=75)
![Chemical structure of (7S,8R,9S,13S,14S,17S)-3-Hydroxy-13-methyl-7-(9-((methylsulfonyl)oxy)nonyl)-6-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1621885-81-1-7S8R9S13S14S17S-3-Hydroxy-13-methyl-7-9-methylsulfonyloxynonyl-6-oxo-78911121314151617-decahydro-6H-cyclopentaaphenanthren-17-yl-acetate.png&w=3840&q=75)
![Chemical structure of (7S,8R,9S,13S,14S,17S)-3-Hydroxy-13-methyl-7-(9-((methylsulfonyl)oxy)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1621885-80-0-7S8R9S13S14S17S-3-Hydroxy-13-methyl-7-9-methylsulfonyloxynonyl-78911121314151617-decahydro-6H-cyclopentaaphenanthren-17-yl-acetate.png&w=3840&q=75)
![Chemical structure of (7S,8R,9S,13S,14S,17S)-7-(9-Bromononyl)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2490287-87-9-7S8R9S13S14S17S-7-9-Bromononyl-3-hydroxy-13-methyl-78911121314151617-decahydro-6H-cyclopentaaphenanthren-17-yl-acetate.png&w=3840&q=75)
![Chemical structure of (7S,8S,9R,13R,14R,17R)-13-Methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F7S8S9R13R14R17R-13-Methyl-7-9-44555-pentafluoropentylsulfinylnonyl-78911121314151617-decahydro-6H-cyclopentaaphenanthrene-317-diol.png&w=3840&q=75)
![Chemical structure of (8R,9S,13S,14S,17S)-3-Hydroxy-13-methyl-7-(9-((methylsulfonyl)oxy)nonyl)-8,9,12,13,14,15,16,17-octahydro-11H-cyclopenta[a]phenanthren-17-yl acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1621885-82-2-8R9S13S14S17S-3-Hydroxy-13-methyl-7-9-methylsulfonyloxynonyl-89121314151617-octahydro-11H-cyclopentaaphenanthren-17-yl-acetate.png&w=3840&q=75)
![Chemical structure of (8R,9S,13S,14S,17S)-4-Bromo-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F8R9S13S14S17S-4-Bromo-13-methyl-7-9-44555-pentafluoropentylsulfinylnonyl-78911121314151617-decahydro-6H-cyclopentaaphenanthrene-317-diol.png&w=3840&q=75)










![Chemical structure of 7β-Acetyloxy-7α-[9-(dimethyl(tert-butylsilyloxy)nonyl]estr-4-en-3-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F875573-60-7-7-Acetyloxy-7-9-dimethyltert-butylsilyloxynonylestr-4-en-3-one.png&w=3840&q=75)
![Chemical structure of 9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonanol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F511545-94-1-9-44555-Pentafluoropentylthiononanol.png&w=3840&q=75)
![Chemical structure of 9-[[9-[(4,4,5,5,5-Pentafluoropentyl)sulfenyl]nonyl]sulfenyl]nonyl Bromide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1391053-14-7-9-9-44555-Pentafluoropentylsulfenylnonylsulfenylnonyl-Bromide.png&w=3840&q=75)























Fulvestrant is a selective estrogen receptor degrader (SERD) indicated for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women. By binding to estrogen receptors and inducing their degradation, this agent effectively blocks estrogen signaling to inhibit tumor growth. The associated reference standards, including structurally validated impurities, metabolites, and stable isotope labelled compounds, are essential tools for pharmaceutical laboratories engaged in rigorous quality control and research. These materials facilitate precise impurity profiling by providing known benchmarks for the identification and quantification of process-related substances and degradation products. Furthermore, stable isotope labelled compounds serve as critical internal standards for accurate analysis in complex biological matrices. Together, these high-quality reference standards support the development and method validation of analytical procedures, ensuring that final drug products meet the stringent consistency and safety requirements mandated by global regulatory guidelines.